Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction

• Status: Withdrawn
• Trial end date: 2017-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate the short-term postoperative outcomes in the abdominal wall reconstruction population using an intraoperative local anesthetic infusion. A prospective randomized double blind study of patients undergoing component separation will be performed in order to assess the following outcomes:

1. Length of Stay (LOS)

2. Return of bowel function

3. Narcotic pain medication requirements

4. Nausea and emesis

5. Pain scores

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Chester Mays
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Subjects to be included are all competent patients, 18 years of age or older, who undergo abdominal component separation for a hernia.

Exclusion Criteria:

• Patients who are not having abdominal component separation or are receiving another form of regional anesthesia will be excluded.

• Patients younger than 18 years of age will be excluded.

• Amide-type local anesthetics, such as bupivacaine, are metabolized by the liver.

• Patients' with hepatic disease, because of their inability to metabolize local anesthetics normally, are at a greater risk of developing toxic plasma concentrations and will therefore be excluded from the study.